D-serine for the Schizophrenia Prodrome

NCT00826202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia Prodrome

Interventions

DRUG: D-serine
OTHER: Placebo

Sponsor

Nathan Kline Institute for Psychiatric Research

Collaborators

[object Object]
[object Object]
[object Object]